8 years ago

Enterprise Therapeutics Secures Funding for Cystic Fibrosis Treatment

  • Enterprise Therapeutics Ltd, a UK-based drug discovery company, received funding from the Cystic Fibrosis Trust to develop new therapies for cystic fibrosis treatment.

      • ProblemHealthcare

      "Enterprise Therapeutics aims to address the challenges in treating respiratory diseases, specifically focusing on finding new drug mechanisms for the treatment of cystic fibrosis (CF)."

      Solution

      "The company has developed a technology platform that includes a miniaturized model of the human airway called bronchosphere. This model is designed to support high-throughput drug and target discovery, as well as facilitate the development of new classes of therapeutics for treating cystic fibrosis."

      Covered on